Suppr超能文献

评价中华稻蝗来源的新型 Xa 因子抑制剂的抗血小板聚集活性。

Evaluation of novel factor Xa inhibitors from Oxya chinensis sinuosa with anti-platelet aggregation activity.

机构信息

College of Pharmacy, CMRI, Research Institute of Pharmaceutical Sciences, BK21 Plus KNU Multi-Omics based Creative Drug Research Team, Kyungpook National University, Daegu, 41566, Republic of Korea.

College of Pharmacy, Chungnam National University, Daejeon, 34134, Republic of Korea.

出版信息

Sci Rep. 2017 Aug 11;7(1):7934. doi: 10.1038/s41598-017-08330-1.

Abstract

The edible grasshopper Oxya chinensis sinuosa is consumed worldwide for its various medicinal effects. The purpose of this study was to investigate potential bioactive antithrombotic and antiplatelet compounds from O. chinensis sinuosa. Five N-acetyldopamine dimers (1-5) were isolated from O. chinensis sinuosa and compounds 1 and 2 were identified as new chemicals with chiral centers at H-2 and H-3 of the benzo-1,4-dioxane structure. Compounds 1-4 were found to have both FXa and platelet aggregation inhibitory activities. These compounds inhibited the catalytic activity of FXa toward its synthetic substrate, S-2222, by noncompetitive inhibition, and inhibited platelet aggregation induced by ADP and U46619. Furthermore, compounds 1-4 showed enhanced antithrombotic effects, which were assessed using in vivo models of pulmonary embolism and arterial thrombosis. The isolated compounds also showed anticoagulant effects in mice. However, compounds 1-4 did not prolong bleeding time in mice, as shown by tail clipping. N-Acetyldopamine dimers, including two new stereoisomers 1 and 2, are novel antithrombotic compounds showing both FXa inhibition and antiplatelet aggregation activity with a low bleeding risk. Collectively, these results suggest that compounds 1-4 could serve as candidates and provide scaffolds for development of new antithrombotic drugs.

摘要

可食用的东亚飞蝗 Oxya chinensis sinuosa 因其多种药用功效而在全球范围内被食用。本研究旨在从东亚飞蝗中寻找具有潜在生物活性的抗血栓和抗血小板化合物。从东亚飞蝗中分离得到 5 个 N-乙酰多巴胺二聚体(1-5),其中化合物 1 和 2 被鉴定为具有手性中心的新型化合物,苯并-1,4-二恶烷结构的 H-2 和 H-3 上具有手性中心。化合物 1-4 均具有 FXa 和血小板聚集抑制活性。这些化合物通过非竞争性抑制抑制 FXa 对其合成底物 S-2222 的催化活性,并抑制 ADP 和 U46619 诱导的血小板聚集。此外,化合物 1-4 显示出增强的抗血栓作用,这通过肺栓塞和动脉血栓形成的体内模型进行评估。分离得到的化合物在小鼠体内也显示出抗凝作用。然而,化合物 1-4 通过剪断尾巴并未延长小鼠的出血时间。包括两个新立体异构体 1 和 2 在内的 N-乙酰多巴胺二聚体是新型抗血栓化合物,具有 FXa 抑制和抗血小板聚集活性,出血风险低。综上所述,这些结果表明,化合物 1-4 可作为候选物,为开发新型抗血栓药物提供了支架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c402/5554137/61684dda3f52/41598_2017_8330_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验